Skip to main content
Log in

Expression of G1 Phase Cyclins in Human Gastric Cancer and Gastric Mucosa of First-Degree Relatives

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the expression of D-type cyclins and cyclin E in gastric cancer patients (N = 34), in healthy first-degree relatives of gastric cancer patients (N = 29), and in control subjects (N = 18). Expression of cyclins D1, D2, D3, and E was determined by RT-PCR. Localization of cyclin expression was determined by immunohistochemistry. Expression of cyclins D2, D3, and E was more frequently detected in tumor tissue compared with tumor-free gastric mucosa (P < 0.05) and was associated with the presence of intestinal metaplasia. In contrast, cyclin D1 was frequently expressed in both tumor- and tumor-free tissue. Cyclin D3 expression was more frequently detected in the antrum mucosa of first-degree relatives compared to controls (P < 0.01) and was associated with the presence of Helicobacter pylori. Our data suggest that deregulation of G1 phase cyclins may play a role in gastric carcinogenesis, and may point to the presence of molecular alterations in individuals at an increased risk for gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Murray CJL, Lopez AD: Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269–1276, 1997

    PubMed  Google Scholar 

  2. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R: Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 218:583–592, 1993

    PubMed  Google Scholar 

  3. Blok P, Craanen ME, Offerhaus GJA, Tytgat GNJ: Gastric carcinoma: clinical, pathogenic and molecular aspects. Q J Med 90:735–749, 1997

    Google Scholar 

  4. Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, Carriero A, Ponz de Leon M: Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66:2047–2051, 1990

    PubMed  Google Scholar 

  5. La Vecchia C, Negri E, Franceschi S, Gentile A: Family history and the risk of stomach and colorectal cancer. Cancer 70:50–55, 1992

    PubMed  Google Scholar 

  6. Kekki M, Ihamäki T, Varis K, Siurala M: Chronic gastritis profiles in sibs of probands calculated to carry a highly increased risk of gastric carcinoma. Scand J Gastroenterol 26:29–32, 1991

    Google Scholar 

  7. Schuman BM, Salerno-Mele P, Ghironzi G, Jackson CE, Ma CK, Spigolon G: Gastric cancer in San Marinese and their first degree relatives in San Marino and the United States. Gastroscopic biopsy as an epidemiological tool. Gastrointest Endosc 33:224–226, 1987

    PubMed  Google Scholar 

  8. Scott N, Lansdown M, Diament R, Rathbone B, Murday V, Wyatt JI, McMahon M, Dixon MF, Quirke P: Helicobacter pylori gastritis and intestinal metaplasia in a gastric cancer family. Lancet 335:728, 1990

    Google Scholar 

  9. Meining A, Bayerdörffer E, Stolte M. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol 11:717–720, 1999

    PubMed  Google Scholar 

  10. Meining A, Hackelsberger A, Daenecke C, Stolte M, Bayerdörffer E, Ochsenkühn T: Increased cell proliferation of the gastric mucosa in first-degree relatives of gastric carcinoma patients. Cancer 83:876–881, 1998

    PubMed  Google Scholar 

  11. Yu J, Miehlke S, Ebert MP, Hoffmann J, Breidert M, Alpen B, Starzynska T, Stolte M, Malfertheiner P, Bayerdörffer E: Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives. Cancer 88:1801–1806, 2000

    PubMed  Google Scholar 

  12. Yu J, Ebert MP, Miehlke S, Rost H, Lendeckel U, Leodolter A, Stolte M, Bayerdörffer E, Malfertheiner P: Alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut 46:639–644, 2000

    PubMed  Google Scholar 

  13. Ebert MP, Günther T, Hoffmann J, Yu J, Miehlke S, Schulz HU, Roessner A, Korc M, Malfertheiner P: Expression of metallothioenin II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res 60:1995–2001, 2000

    PubMed  Google Scholar 

  14. Ebert M, Yu J, Miehlke S, Lendeckel U, Neubauer A, Stolte M, Bayerdörffer E, Malfertheiner P: Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer 82:1795–1800, 2000

    PubMed  Google Scholar 

  15. Lew DJ, Dulic V, Reed SI: Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66:1197–1206, 1991

    Article  PubMed  Google Scholar 

  16. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT: Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13: 565–574, 1992

    PubMed  Google Scholar 

  17. Sherr CJ: Cancer cell cycles. Science 274:1672–1677, 1996

    Article  PubMed  Google Scholar 

  18. Tahara E, Semba S, Tahara H: Molecular biological observations in gastric cancer. Semin Oncol 23:307–315, 1996

    PubMed  Google Scholar 

  19. Zhou P, Jiang W, Weghorst CM, Weinstein IB: Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56:36–39, 1996

    PubMed  Google Scholar 

  20. Houldsworth J, Reuter V, Bosl GJ, Chaganti RS: Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ 8:293–299, 1997

    PubMed  Google Scholar 

  21. Bartkova J, Lukas J, Strauss M, Bartek J: Cyclin D3: Requirement for G1/S transition and high abundance in quiescent tissue suggest a dual role in proliferation and differentiation. Oncogene 17:1027–1037, 1998

    PubMed  Google Scholar 

  22. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM: Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66:1217–1228, 1991

    PubMed  Google Scholar 

  23. Fujii S, Tominaga O, Nagawa H, Tsuno N., Nita ME, Tsurno T, Muto T: Quantitative analysis of the cyclin expression in human esophageal cancer cell lines. J Exp Clin Cancer Res 17:491–496, 1998

    PubMed  Google Scholar 

  24. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T: Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146:1161–1169, 1995

    PubMed  Google Scholar 

  25. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger HG: Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 57:1634–1637, 1997

    PubMed  Google Scholar 

  26. Kornmann M, Ishiwata T, Itakura J, Tangvoranuntakul P, Beger HG, Korc M: Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology 55:363–369, 1998

    PubMed  Google Scholar 

  27. Sutter T, Sadayuki D, Carnevale KA, Arber N, Weinstein B: Expression of cyclins D1 and E in human colon adenocarcinoma. J Med 28:285–309, 1997

    PubMed  Google Scholar 

  28. Leach FS, Elledge SJ, Sherr CJ, Wilson JK, Markowitz S, Kinzler KW, Vogelstein B: Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53:1986–1989, 1993

    PubMed  Google Scholar 

  29. Watson DS, Brotherick I, Shenton BK, Wilson RG, Angus B, Varma JS, Campbell FC: Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer. Oncology 56:66–72, 1999.

    PubMed  Google Scholar 

  30. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, Tahara E: Frequent amplification of the cyclin E gene in human gastric carcinomas. Jon J Cancer Res 86:617–621, 1995

    Google Scholar 

  31. Ahn MJ, Kim BH, Jang SJ, Hong EK, Lee WM, Baik HK, Park HK, Lee CB, Ki M: Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance. J Korean Med Sci 13:513–518, 1998

    PubMed  Google Scholar 

  32. Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E: Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J Exp Ther Oncol 1:88–94, 1996

    PubMed  Google Scholar 

  33. Sasaki H, Ishizuka T, Igaki H, Terada M: Mutation frequency of the p16/CDKN2 gene and amplification of the cyclin E gene in human primary gastric carcinomas. Nippon Rinsho 54:1049–1053, 1996

    PubMed  Google Scholar 

  34. Takano Y, Kato Y, van Diest PJ, Masuda M, Mitomi H, Okayasu I: Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 156:585–594, 2000

    PubMed  Google Scholar 

  35. Sobin L, Wittekind C (eds.): TNM Classification of Malignant Tumours, 5th ed. New York, Wiley-Liss, 1997, pp 43–46

    Google Scholar 

  36. Dixon MF, Genta RM, Yardley JH, Correa P, and participants: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161–1181, 1996

    PubMed  Google Scholar 

  37. Lauren P: The two main histological types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–39, 1965

    PubMed  Google Scholar 

  38. De Toledo SM, Azzam EI, Gasmann MK, Mitchel RE: Use of semiquantitative reverse transcription-polymerase chain reaction to study gene expression in normal human skin fibroblasts following low dose-rate irradiation. Int J Radiat Biol 67:135–143, 1995

    PubMed  Google Scholar 

  39. Yasogawa Y, Takano Y, Okayasu I, Kakita A: The 5D4 antibody (anti-cyclin D1/D2) related antigen: Cytoplasmic staining is correlated to the progression of gastric cancer. Pathol Int 48:717–722, 1998

    PubMed  Google Scholar 

  40. Yatabe Y, Nakamura S, Seto M, Kuroda H, Kagami Y, Suzuki R, Ogura M, Kojima M, Koshikawa T, Ueda R, Suchi T: Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. Am J Surg Pathol 20:1110–1122, 1996

    PubMed  Google Scholar 

  41. Bringuier PP, Tamimi Y, Schuring E, Schalken J: Expression of cyclin D1 and EMS1 in bladder tumours: Relationship with chromosome 11q13 amplification. Oncogene 12:1747–1753, 1996

    PubMed  Google Scholar 

  42. Lazzereschi D, Sambuco L, Carnovale Scalzo C, Ranieri A, Mincione G, Nardi F, Colletta G: Cyclin D1 and Cyclin E expression in malignant thyroid cells and in human thyroid carcinomas. Int J Cancer 76:806–811, 1998

    PubMed  Google Scholar 

  43. Delmer A, Ajchenbaum-Cymbalista F, Tang R, Ramond S, Faussat AM, Marie JP, Zittoun R: Overexpression of cyclin D2 in chronic B-cell malignancies. Blood 85:2870–2876, 1995

    PubMed  Google Scholar 

  44. Russell A, Thompson MA, Hendley J, Trute L, Armes J, Germain D: Cyclin D1 and D3 are associated with the SCF complex and are coordinately elevated in breast cancer. Oncogene 18:1983–1991, 1999

    PubMed  Google Scholar 

  45. Correa P: A human model of gastric carcinogenesis. Cancer Res 48:3554–3560, 1988

    PubMed  Google Scholar 

  46. El-Omar EM, Oien K, Murray LS, El Nujumi A, Wirz A, Gillen D, Williams C, McColl KEL: Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 118:22–30, 2000

    PubMed  Google Scholar 

  47. El Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JR Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402, 2000

    Article  PubMed  Google Scholar 

  48. Shirin H, Sordillo EM, Oh SH, Yamamoto H, Dolhery T, Weinstein B, Moss SF: Helicobacter pylori inhibits the G1 to S transition in AGS epithelial cells. Cancer Res 59:2277–2281, 1999

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miehlke, S., Yu, J., Ebert, M. et al. Expression of G1 Phase Cyclins in Human Gastric Cancer and Gastric Mucosa of First-Degree Relatives. Dig Dis Sci 47, 1248–1256 (2002). https://doi.org/10.1023/A:1015358127751

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015358127751

Navigation